About RejuvenAir
RejuvenAir is a company based in Lexington (United States) founded in 2006.. RejuvenAir has raised $171.11 million across 14 funding rounds from investors including Horizon Tech Finance, SV Health Investors and Ascension Ventures. RejuvenAir offers products and services including RejuvenAir System and SPRAY-CB Clinical Trial. RejuvenAir operates in a competitive market with competitors including Nuvaira, Asthmatx and D R Burton, among others.
- Headquarter Lexington, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Csa Medical, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$171.11 M (USD)
in 14 rounds
-
Latest Funding Round
$59.66 M (USD), Series F
Aug 30, 2024
-
Investors
Horizon Tech Finance
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RejuvenAir
RejuvenAir offers a comprehensive portfolio of products and services, including RejuvenAir System and SPRAY-CB Clinical Trial. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Applies liquid nitrogen to treat Chronic Bronchitis airways.
Evaluates cryotherapy for reducing COPD symptoms.
Unlock access to complete
Funding Insights of RejuvenAir
RejuvenAir has successfully raised a total of $171.11M across 14 strategic funding rounds. The most recent funding activity was a Series F round of $59.66 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Series F — $59.7M
-
First Round
First Round
(01 Jun 2007)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Series F - RejuvenAir | Valuation |
investors |
|
| Feb, 2019 | Amount | Series E - RejuvenAir | Valuation |
investors |
|
| Feb, 2019 | Amount | Debt – Conventional - RejuvenAir | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in RejuvenAir
RejuvenAir has secured backing from 9 investors, including venture fund investors. Prominent investors backing the company include Horizon Tech Finance, SV Health Investors and Ascension Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on early-stage healthcare startups
|
Founded Year | Domain | Location | |
|
Strategic investments in healthcare technologies and data innovations.
|
Founded Year | Domain | Location | |
|
Early-stage life sciences and tech focused VC firm funding companies in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by RejuvenAir
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - RejuvenAir
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rejuvenair Comparisons
Competitors of RejuvenAir
RejuvenAir operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuvaira, Asthmatx and D R Burton, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A catheter-based system for COPD treatment is developed and provided.
|
|
| domain | founded_year | HQ Location |
Bronchial thermoplasty devices are developed for adult asthma treatment.
|
|
| domain | founded_year | HQ Location |
Provides comprehensive products for positive pressure therapy in lung disease patients.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rejuvenair
Frequently Asked Questions about RejuvenAir
When was RejuvenAir founded?
RejuvenAir was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Where is RejuvenAir located?
RejuvenAir is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Is RejuvenAir a funded company?
RejuvenAir is a funded company, having raised a total of $171.11M across 14 funding rounds to date. The company's 1st funding round was a Series E of $45.22M, raised on Jun 01, 2007.
What does RejuvenAir do?
RejuvenAir was founded in 2006 and is located in Lexington, United States. A cryosurgical system targeting chronic bronchitis and COPD is developed within the medical device sector. Metered doses of cryogen spray are delivered via software-controlled dosimetry and specialized catheters to flash freeze damaged airway surfaces. Mucous production, cough, and inflammation are thereby reduced in affected patients. Operations focus on respiratory therapy innovations for clinical applications.
Who are the top competitors of RejuvenAir?
RejuvenAir's top competitors include Nuvaira, Asthmatx and D R Burton.
What products or services does RejuvenAir offer?
RejuvenAir offers RejuvenAir System and SPRAY-CB Clinical Trial.
Who are RejuvenAir's investors?
RejuvenAir has 9 investors. Key investors include Horizon Tech Finance, SV Health Investors, Ascension Ventures, Intersouth Partners, and Blue Heron Capital.